A Study of HW243040 in Healthy Participants

Starting soon · Phase 1 · Has a placebo group

Conditions studied: Healthy

In brief

This is a randomised, double-blind, placebo-controlled clinical trial intended to evaluate the safety, tolerability and pharmacokinetic profiles of HW243040 following single and multiple administrations in healthy study participants.

Key facts

Study ID

NCT07737496

Run by

Hubei Bio-Pharmaceutical Industrial Technological Institute Inc.

People needed

98

Starts

2026-08-10

Expected to finish

2027-05-31

Last updated by the study team

2026-07-31

Who can join

Age: 18 and older, up to 55. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Informed consent must be obtained/signed prior to trial participation.
• Aged between 18 and 55 years old, both healthy males and females are eligible.
• Female participates must have a body weight of ≥ 45 kg and male participates ≥ 50 kg, with a body mass index (BMI) ranging from 19 to 26 kg/m\^2.

You may not qualify if…

• History or presence of any clinically severe disorders of urinary, cardiovascular, endocrine, nervous, gastrointestinal, respiratory, hematologic, immune systems, psychiatric illnesses or metabolic abnormalities; or other conditions judged by the Investigator to confound trial outcomes, e.g., intestinal diseases (irritable bowel syndrome), urinary tract infections.
• History of malignant tumors (except for cancer with confirmed cure or remission for ≥5 years, radically resected basal or squamous cell skin cancer, carcinoma in situ of the cervix, and resected colonic polyps).
• Any conditions or diseases that, in the Investigator's judgment, may affect the absorption, metabolism and/or excretion of the investigational product.
• History of drug abuse or dependence.
• Hypersensitivity to any ingredient of the study drug，or history of allergic disorders or allergic diathesis.
• Any other condition that, in the opinion of the investigator, renders the participant unsuitable to participate in the study.

Where it is running

• The Third Xiangya Hospital of Central South University — Changsha, Hunan, China

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.